Global Medical Affairs Lead - Dermatology (AD/HS)

BioSpace; Morristown (NJ); On-site; USD 180,000 - 240,000; Full time

Benefits offered by this job

Health benefits

Parental leave (14+ weeks)

Wellbeing programs

Job summary

Sanofi is seeking an Associate Director, Global Medical Affairs Dermatology to lead global medical strategy across Atopic Dermatitis, HS, and early dermatology programs. You will translate emerging science and external insights into integrated medical objectives and drive high-impact execution with cross-functional teams.

You will build scientific partnerships, shape evidence-generation plans, and provide medical input into development programs, advisory boards, and publications while

Qualifications

• Minimum PharmD, PhD, MD, or equivalent doctoral degree.
• Postdoctoral fellowship training preferred.
• Minimum 3 years in pharma/biotech with progression of responsibility.
• Dermatology experience, Atopic Dermatitis/HS valued.
• Strong scientific communication and collaboration skills.

Responsibilities

• Develop and maintain global dermatology medical affairs partnerships to align strategy and execution across geographies.
• Lead integrated medical strategies for AD, early-stage dermatology, and HS portfolios.
• Collaborate with Clinical Development, Translational Medicine, Commercial, Regulatory, Safety, and Publications to advance strategies.
• Contribute to evidence-generation planning: clinical data, real-world evidence, publications.

Skills

Dermatology knowledge

Medical affairs leadership

Scientific communication

Education

PharmD/PhD/MD or equivalent

Job description

Sanofi is seeking an Associate Director, Global Medical Affairs Dermatology to lead global medical strategy across Atopic Dermatitis, HS, and early dermatology programs. You will translate emerging science and external insights into integrated medical objectives and drive high-impact execution with cross-functional teams.

You will build scientific partnerships, shape evidence-generation plans, and provide medical input into development programs, advisory boards, and publications while